Termination Of Collaboration With Cardiome Pharma Corp. (“Cardiome”) (Details) - USD ($)	1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	Aug. 31, 2015	Dec. 31, 2015	Dec. 31, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues				$ 157,257,000	$ 134,790,000	$ 127,058,000
Product returns reserve amount				100,000	100,000
Inventories		$ 10,976,000	$ 10,976,000	10,976,000	10,703,000
Cardiome [Member]
Transition payments to be received	$ 750,000
Transition payments to be received, period	1 year
Transition payments received			450,000
Payment received for repurchased inventory		1,100,000
Reduction in cost of product sales		1,100,000
Aggrastat Product Sales [Member] | Cardiome [Member]
Revenues				1,800,000	$ 1,100,000	$ 0
Product returns reserve amount				600,000
Inventories		$ 0	$ 0	$ 0